Clinical Trial Update: Evaluation of the Long-term Persistence of GlaxoSmithKline (GSK) Biologicals' Candidate Cytomegalovirus (CMV) Vaccine [NA]

View source ↗

Summary

A completed clinical trial update evaluating the long-term persistence of GSK's cytomegalovirus vaccine candidate, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infections

Drugs mentioned

• CMV vaccine candidate

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Cytomegalovirus | NA | Status: COMPLETED | Results posted: 2017-10-06